Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25344606
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Biol+Chem
2014 ; 289
(50
): 34627-41
Nephropedia Template TP
Lu J
; Isaji T
; Im S
; Fukuda T
; Hashii N
; Takakura D
; Kawasaki N
; Gu J
J Biol Chem
2014[Dec]; 289
(50
): 34627-41
PMID25344606
show ga
?-Galactoside ?2,6-sialyltranferase 1 (ST6GAL1) catalyzes the addition of
terminal ?2,6-sialylation to N-glycans. Increased expression of ST6GAL1 has been
reported in diverse carcinomas and highly correlates with tumor progression.
Here, we report that St6gal1 transcription and ?2,6-sialylated N-glycans are
up-regulated during TGF-?-induced epithelial-mesenchymal transition (EMT) in GE11
cells, requiring the Sp1 element within the St6gal1 promoter. Knockdown of
St6gal1 strongly suppressed TGF-?-induced EMT with a concomitant increase in
E-cadherin expression, a major determinant of epithelial cell adherens junctions.
Conversely, overexpression of ST6GAL1 increased the turnover of cell surface
E-cadherin and promoted TGF-?-induced EMT. Overexpressing ?-galactoside
?2,3-sialyltranferase 4 had little influence on EMT, indicating specificity for
?2,6-sialylation. The basal mesenchymal phenotype of MDA-MB-231 human breast
cancer cells was partially reversed by ST6GAL1 silencing. Moreover, ST6GAL1
knockdown inhibited the phosphorylation of Akt, but not Smad2, suggesting that
ST6GAL1 contributes to EMT through a non-Smad signaling pathway. Taken together,
our data indicate that ST6GAL1 promotes TGF-?-dependent EMT as well as
maintenance of the mesenchymal state by growth signaling, providing a plausible
mechanism whereby up-regulated ST6GAL1 may promote malignant progression.